BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/25/2023 7:09:14 AM | Browse: 353 | Download: 1354
 |
Received |
|
2023-05-21 09:27 |
|
Peer-Review Started |
|
2023-05-21 09:28 |
|
First Decision by Editorial Office Director |
|
2023-07-10 04:27 |
|
Return for Revision |
|
2023-07-10 04:27 |
|
Revised |
|
2023-07-20 03:34 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2023-08-09 02:57 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2023-08-09 08:29 |
|
Articles in Press |
|
2023-08-09 08:29 |
|
Edit the Manuscript by Language Editor |
|
2023-08-06 03:20 |
|
Typeset the Manuscript |
|
2023-08-21 12:20 |
|
Publish the Manuscript Online |
|
2023-08-25 07:09 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Cohort Study |
| Article Title |
Validation of the albumin-bilirubin score for identifying decompensation risk in patients with compensated cirrhosis
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Huttakan Navadurong, Kessarin Thanapirom, Salisa Wejnaruemarn, Thaninee Prasoppokakorn, Roongruedee Chaiteerakij, Piyawat Komolmit and Sombat Treeprasertsuk |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Sombat Treeprasertsuk, MD, PhD, Professor, Division of Gastroenterology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, 1873 Rama 4 Road, Pathumwan District, Bangkok 10330, Thailand. battan5410@gmail.com |
| Key Words |
Albumin-bilirubin score; Compensated cirrhosis; Hepatic decompensation risk |
| Core Tip |
The albumin-bilirubin (ALBI) score has been successfully applied to the prediction of survival in patients with non-malignant liver diseases of various etiologies. This study demonstrated that the ALBI score can accurately identify decompensation risk at the 3-year follow-up in patients with compensated cirrhosis. The ALBI score is a simple and ready-to-use tool to help clinicians monitor and make appropriate treatment strategies in patients with compensated cirrhosis. |
| Publish Date |
2023-08-25 07:09 |
| Citation |
Navadurong H, Thanapirom K, Wejnaruemarn S, Prasoppokakorn T, Chaiteerakij R, Komolmit P, Treeprasertsuk S. Validation of the albumin-bilirubin score for identifying decompensation risk in patients with compensated cirrhosis. World J Gastroenterol 2023; 29(32): 4873-4882
|
| URL |
https://www.wjgnet.com/1007-9327/full/v29/i32/4873.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v29.i32.4873 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
